Hinge Health, Inc.
Hinge Health, Inc. is listed today as Hinge Health, Inc.: market value, financials and filings are on its company page.
Funding rounds
7 counted as startup funding, 1 other private sales on record. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Oct 2021 | $400 M | No. 7 | $250 million to $1 billion | equity | SEC | |
| Mar 2021 | $10 M | Issued in a merger or acquisition | $2 to $10 million | equity | SEC | |
| Dec 2020 | $309 M | No. 6 | $250 million to $1 billion | equity, options | SEC | |
| Jan 2020 | $92 M | No. 5 | $50 to $250 million | equity, options | SEC | |
| May 2019 | $15 M | No. 4 | $10 to $50 million | debt, options | SEC | |
| Jul 2018 | $26 M | No. 3 | $10 to $50 million | equity, options | SEC | |
| Jul 2017 | $10 M | No. 2 | $2 to $10 million | equity, options | SEC | |
| Apr 2016 | $1 M | No. 1 | Under $2 million | equity | SEC |
Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
As the listed company Hinge Health, Inc., its revenue in fiscal 2025 came from these business segments: Reportable $587.86 million (100%).
Annual report (SEC XBRL) · Dec 2025
Hinge Health, Inc. chose not to state its revenue in its newest notice of a funding round (Dec 2023).
SEC Form D · Dec 2023
The industry group it chose in its notices: Other Technology.
SEC Form D · Dec 2023
Products and services#
No products or services of Hinge Health, Inc. are on record.
Investors#
19 named in official filings. Open an investor to see everything it has backed.
| Investor | Kind | Amount | Round | Role | Source |
|---|---|---|---|---|---|
| 11.2 Capital HH, LLC | Fund or asset manager | not stated | not stated | Held Series A-1, A-2, C, D and S-1 preferred stock, 10% owner (Form 3, 2025) | SEC Form 3 |
| 11.2 Capital I, L.P. | Fund or asset manager | not stated | not stated | Held Series A-1, A-2, C, D and S-1 preferred stock, 10% owner (Form 3, 2025) | SEC Form 3 |
| 11.2 Capital I Partners, LLC | Fund or asset manager | not stated | not stated | Held Series A-1, A-2, C, D and S-1 preferred stock, 10% owner (Form 3, 2025) | SEC Form 3 |
| 11.2 Capital Ivy, LLC | Fund or asset manager | not stated | not stated | Held Series A-1, A-2, C, D and S-1 preferred stock, 10% owner (Form 3, 2025) | SEC Form 3 |
| 11.2 Capital Ivy Partners, LLC | Fund or asset manager | not stated | not stated | Held Series A-1, A-2, C, D and S-1 preferred stock, 10% owner (Form 3, 2025) | SEC Form 3 |
| Atomico Advisors IV, Ltd. | Fund or asset manager | not stated | not stated | Held Series A-2, B, C, C-1 and D preferred stock, 10% owner (Form 3, 2025) | SEC Form 3 |
| Atomico IV (Guernsey), L.P. | Fund or asset manager | not stated | not stated | Held Series A-2, B, C, C-1 and D preferred stock, 10% owner (Form 3, 2025) | SEC Form 3 |
| Atomico IV, L.P. | Fund or asset manager | not stated | not stated | Held Series A-2, B, C, C-1 and D preferred stock, 10% owner (Form 3, 2025) | SEC Form 3 |
| Bessemer Venture Partners X Institutional L.P. | Venture capital | not stated | not stated | Held Series C and D preferred stock, 10% owner (Form 3, 2025) | SEC Form 3 |
| Bessemer Venture Partners X L.P. | Venture capital | not stated | not stated | Held Series C and D preferred stock, 10% owner (Form 3, 2025) | SEC Form 3 |
| Deer X & Co. L.P. | Fund or asset manager | not stated | not stated | Held Series C and D preferred stock, 10% owner (Form 3, 2025) | SEC Form 3 |
| Deer X & Co. Ltd. | Company | not stated | not stated | Held Series C and D preferred stock, 10% owner (Form 3, 2025) | SEC Form 3 |
| Insight Holdings Group, LLC | Fund or asset manager | not stated | not stated | Held Series B, C, C-1 and D preferred stock, 10% owner (Form 3, 2025) | SEC Form 3 |
| Insight Venture Associates X, L.P. | Venture capital | not stated | not stated | Held Series B, C, C-1 and D preferred stock, 10% owner (Form 3, 2025) | SEC Form 3 |
| Insight Venture Associates X, Ltd. | Venture capital | not stated | not stated | Held Series B, C, C-1 and D preferred stock, 10% owner (Form 3, 2025) | SEC Form 3 |
| Insight Venture Partners (Cayman) X, L.P. | Venture capital | not stated | not stated | Held Series B, C, C-1 and D preferred stock, 10% owner (Form 3, 2025) | SEC Form 3 |
| Insight Venture Partners (Delaware) X, L.P. | Venture capital | not stated | not stated | Held Series B, C, C-1 and D preferred stock, 10% owner (Form 3, 2025) | SEC Form 3 |
| Insight Venture Partners X (Co-Investors), L.P. | Venture capital | not stated | not stated | Held Series B, C, C-1 and D preferred stock, 10% owner (Form 3, 2025) | SEC Form 3 |
| Insight Venture Partners X, L.P. | Venture capital | not stated | not stated | Held Series B, C, C-1 and D preferred stock, 10% owner (Form 3, 2025) | SEC Form 3 |
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 7 rounds above had up to 21 investors.
Largest shareholders today
Institutions holding Hinge Health, Inc. shares, as of Sep 30, 2026.
- BlackRock, Inc.$429 M5.39%
- Two Sigma Investments, LP$249 M3.12%
- Vanguard Capital Management LLC$244 M3.07%
- Vanguard Portfolio Management LLC$242 M3.04%
- Morgan Stanley$239 M3.00%
- 11.2 Capital Management, LLC$229 M2.87%
- Franklin Templeton Inc$198 M2.49%
- Acadian Asset Management LLC$191 M2.40%
- Assenagon Asset Management S.A.$180 M2.26%
- Arrowstreet Capital, Limited Partnership$180 M2.26%
- Fuller & Thaler Asset Management, Inc.$172 M2.16%
- Goldman Sachs Group Inc$165 M2.08%
- Wellington Management Group LLP$141 M1.77%
- Renaissance Technologies LLC$135 M1.69%
- Invesco Ltd.$128 M1.61%
Source: SEC Form 13F holdings reports · as of Sep 30, 2026. Value held and share of the company. All holders are on the company page.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Alexander Annison | Executive officer | Dec 2023 |
| Daniel Perez | Executive officer | Dec 2023 |
| David Wood | Executive officer | Dec 2023 |
| Gabriel Mecklenburg | Executive officer | Dec 2023 |
| James Budge | Executive officer | Dec 2023 |
| Jeffrey Krauss | Executive officer | Dec 2023 |
| Jim Pursley | Executive officer | Dec 2023 |
| Lalith Vadlamannati | Executive officer | Dec 2023 |
| Mario Queiroz | Executive officer | Dec 2023 |
| Ron Will | Executive officer | Apr 2021 |
| Ben Blume | Director | Dec 2023 |
| Daniel Perez | Director | Dec 2023 |
| Elliott Robinson | Director | Dec 2023 |
| Gabriel Mecklenburg | Director | Dec 2023 |
| Teddie Wardi | Director | Dec 2023 |
| Carolina Brochado | Director | Jul 2020 |
| Peter Segall | Director | Jul 2020 |
| Steve Kraus | Director | Jul 2020 |
Went public since 2025. Its SEC number is that of a company listed on a stock exchange.